Salient Pharmaceuticals
Houston
About Salient Pharmaceuticals
Salient is a Texas-based company formed in 2007 to explore the pharmaceutical application of its proprietary composition of a rare, all-natural mineral. This composition has been proven to adsorb a range of toxins and inflammatory proteins commonly associated with diarrhea. Salient’s compound, CASAD™, is envisioned to be a “platform“ product effective across a spectrum of conditions from Cancer Therapy-Induced Diarrhea to infectious disease and chronic GI conditions. It also has the potential to be used as a rescue agent for other drugs with toxic side effects.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Non-Equity Assistance (Aug 2011)
- Website: salientpharmaceuticals.com
- Phone: 713-589-9859
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/salient-pharmaceuticals-1380248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.